What’s Next for Oncology? Strategic Perspectives Following ASCO 2026
Watch On-Demand
ASCO 2026 showcased important advances across oncology, but the implications extend far beyond individual datasets.
Watch Prescient’s on-demand webinar exploring how evolving evidence expectations, increasing competitive intensity and a rapidly changing global landscape are shaping the future of oncology.
Bringing together perspectives from competitive intelligence, medical strategy and evidence generation, commercial strategy and market insights, and pricing and market access, our panel discusses what oncology teams should be thinking about now and how these developments may influence future decision-making.
What You’ll Explore
- Evolving evidence expectations and their implications for oncology development
- Differentiation and market shaping in increasingly crowded oncology markets
- Global innovation trends, policy developments and market dynamics shaping future strategy
Featured Speakers
Gordon Gochenauer, Associate Partner
Ryan Caradonna, Global Practice Lead – Partner
Stephanie Hall, Chief Innovation and Strategy Officer
Katy Chun, Client Partner, Co-Lead Medical
Adam Hutchings, Managing Director, Dolon (part of Prescient)
